Table 2.
PsA colonization, BPI-ANCA, and outcome. Adult CF-patients divided into groups based on Leeds classification and IgA BPI-ANCA levels at baseline and subsequent endpoints during followup.
| Leeds classification | Leeds I + II | Leeds III | Leeds IV | ||||||
|---|---|---|---|---|---|---|---|---|---|
| BPI-ANCA level | BPI− | BPI+ | BPI++ | BPI− | BPI+ | BPI++ | BPI− | BPI+ | BPI++ |
| Inclusion (n) | 5 | 12 | 9 | 6** | 1 | 1 | 6 | 5* | 1 |
| 5 years % with endpoint | 0 | 16.7% | 33.3% | 16.7% | 0 | 0 | 0 | 20% | 0 |
| (n with endpoint) | (2) | (3) | (1) | (1*) | |||||
| 10 years % with endpoint | 0 | 33.3% | 77.8% | 33.3% | 0 | 100% | 0 | 20% | 0 |
| (n with endpoint) | (4) | (7) | (2**) | (1) | (1*) | ||||
| Last followup, % with endpoint | 20% | 41.7% | 88.9% | 33.3% | 0 | 100% | 0 | 40% | 0 |
| (n with endpoint) | (1) | (5) | (8) | (2**) | (1) | (2*) | |||
*Patient with colon cancer.
**Patient with Burkholderia cepacia.